Veerhealth Signs Contract Manufacturing Deal with Top Marketplace
ECONOMY & POLICY

Veerhealth Signs Contract Manufacturing Deal with Top Marketplace

Veerhealth Care, Ayuveer, backed by Veerhealth Care's expertise in Ayurveda, specializes in crafting ayurvedic medicines and oral care products with natural ingredients. With a focus on quality and affordability, Ayuveer aims to offer an exceptional and safe daily care experience to its customers.

Veerhealth Care has entered into a strategic Contract Manufacturing Agreement with a company having top position in personal care segment on marketplace companies in the country for the production of its private-label personal care range of products.

Under the terms of the agreement, company will manufacture and supply personal care range of products exclusively tailored to the company's brand specifications and quality standards. Company is in the process of regulatory approval which is expected to be completed soon and commercial production is expected to begin soon.

This development is expected to have a positive impact on the company's revenue and capacity utilisation in the coming quarters.

Commenting on the achievement, Bhavin Shah - Managing Director of Veerhealth Care, said, “We are exhilarated to announce this partnership which marks a significant milestone in company's growth strategy, further strengthening our position in the personal care manufacturing sector.

To meet the increased demand from both Domestic and Exports, Company will be operating at Full capacity which will help in reducing the overall costs and boosting Total Income and PAT. In coming Quarters, we expect to more than fully recover the reduction in Total Income and PAT caused by USFDA Inspection as dispatches for Exports have started.

We are working aggressively towards business of manufacturing and exports of products under medical device category in the US. Company is expected to complete formalities pertaining to the medical device category with the USFDA.

Our ability to secure multiple high-value export orders, including those from top institutional suppliers, underscores the trust in our product, quality and commitment to excellence. The expansion of our manufacturing footprint further reflects our proactive approach to meeting growing demand and enhancing our production capabilities. These achievements are a testament to our strategy and pave the way for sustained growth and value creation in the coming quarters."

For successfully clearing the USFDA Inspection the Company had to expand, renovate and upgrade the Manufacturing facility due to which Production was impacted in the past 6-9 months, also Exports were halted for USFDA clearance which resulted in Inventory pile up. Company has now started dispatching for Exports.

Products / Services offered by Veerhealth Care:

Contract Manufacturing – Veerhealth Care manufacture products on behalf of Brands to meet their requirements. The Brands give the company specifications about the products to be manufactured.

White Labelling – Veerhealth Care manufactures generic products that retailers can sell under their own Brands.

Product Research & Development – Veerhealth Care has extensive in-house R&D facility for designing, testing and manufacturing. Company has the capability of creating various new products. Till now Company has launched more than 100 products through this.

Customised Product Formulations – Veerhealth Care has the capability of manufacturing specialised product formulations customised for the Brands. Due to customisation the products can meet the standard specifications of the Brands.

Veerhealth Care has established a new division focused on hospital care, which includes partnering with a leading manufacturer and exporter of medical equipment. This new division will offer a range of equipment, including ventilators, defibrillators, infusion pumps, syringe pumps, and other accessories. Company intends to supply these products to government organizations and hospitals.

VeerPlast is a division of Veerhealth Care. It is a plastic moulding company, providing high-quality plastic products to various industries. At VeerPlast, Company takes pride in being a manufacturer of high-quality toothbrushes, dedicated to promoting superior oral hygiene through precision and commitment to excellence.

The Company is expecting to get a substantial addition to its revenue in the current financial year. In F.Y. 2025-26, Company is expecting Total Revenues of Rs 305-400 million with PAT of 10 per cent.


Veerhealth Care, Ayuveer, backed by Veerhealth Care's expertise in Ayurveda, specializes in crafting ayurvedic medicines and oral care products with natural ingredients. With a focus on quality and affordability, Ayuveer aims to offer an exceptional and safe daily care experience to its customers.Veerhealth Care has entered into a strategic Contract Manufacturing Agreement with a company having top position in personal care segment on marketplace companies in the country for the production of its private-label personal care range of products.Under the terms of the agreement, company will manufacture and supply personal care range of products exclusively tailored to the company's brand specifications and quality standards. Company is in the process of regulatory approval which is expected to be completed soon and commercial production is expected to begin soon.This development is expected to have a positive impact on the company's revenue and capacity utilisation in the coming quarters.Commenting on the achievement, Bhavin Shah - Managing Director of Veerhealth Care, said, “We are exhilarated to announce this partnership which marks a significant milestone in company's growth strategy, further strengthening our position in the personal care manufacturing sector.To meet the increased demand from both Domestic and Exports, Company will be operating at Full capacity which will help in reducing the overall costs and boosting Total Income and PAT. In coming Quarters, we expect to more than fully recover the reduction in Total Income and PAT caused by USFDA Inspection as dispatches for Exports have started.We are working aggressively towards business of manufacturing and exports of products under medical device category in the US. Company is expected to complete formalities pertaining to the medical device category with the USFDA.Our ability to secure multiple high-value export orders, including those from top institutional suppliers, underscores the trust in our product, quality and commitment to excellence. The expansion of our manufacturing footprint further reflects our proactive approach to meeting growing demand and enhancing our production capabilities. These achievements are a testament to our strategy and pave the way for sustained growth and value creation in the coming quarters.For successfully clearing the USFDA Inspection the Company had to expand, renovate and upgrade the Manufacturing facility due to which Production was impacted in the past 6-9 months, also Exports were halted for USFDA clearance which resulted in Inventory pile up. Company has now started dispatching for Exports.Products / Services offered by Veerhealth Care:Contract Manufacturing – Veerhealth Care manufacture products on behalf of Brands to meet their requirements. The Brands give the company specifications about the products to be manufactured.White Labelling – Veerhealth Care manufactures generic products that retailers can sell under their own Brands.Product Research & Development – Veerhealth Care has extensive in-house R&D facility for designing, testing and manufacturing. Company has the capability of creating various new products. Till now Company has launched more than 100 products through this.Customised Product Formulations – Veerhealth Care has the capability of manufacturing specialised product formulations customised for the Brands. Due to customisation the products can meet the standard specifications of the Brands.Veerhealth Care has established a new division focused on hospital care, which includes partnering with a leading manufacturer and exporter of medical equipment. This new division will offer a range of equipment, including ventilators, defibrillators, infusion pumps, syringe pumps, and other accessories. Company intends to supply these products to government organizations and hospitals.VeerPlast is a division of Veerhealth Care. It is a plastic moulding company, providing high-quality plastic products to various industries. At VeerPlast, Company takes pride in being a manufacturer of high-quality toothbrushes, dedicated to promoting superior oral hygiene through precision and commitment to excellence.The Company is expecting to get a substantial addition to its revenue in the current financial year. In F.Y. 2025-26, Company is expecting Total Revenues of Rs 305-400 million with PAT of 10 per cent.

Next Story
Infrastructure Urban

Jyoti Structures FY26 profit rises 56.5%

Jyoti Structures (JSL) recently reported strong financial results for the quarter and year ended 31 March 2026, driven by disciplined execution, cost management and steady progress across its order book.For Q4 FY2025-26, total income rose 44.2 per cent to Rs 2.41 billion from Rs 1.67 billion in Q4 FY2024-25. EBITDA increased 58.6 per cent to Rs 237 million, while EBITDA margin improved by 89 basis points to 9.84 per cent. Profit before tax grew 53.3 per cent to Rs 188.5 million, and net profit rose 51.9 per cent to Rs 181.4 million.For FY2025-26, total income grew 53.1 per cent to Rs 7.72 bill..

Next Story
Infrastructure Energy

Cat BEPU to Power Doppstadt Separator at IFAT 2026

Caterpillar’s Cat Battery Electric Power Unit (BEPU) has been selected by Doppstadt to power its SWS 6 Spiral Shaft Separator, which will be showcased for the first time at IFAT 2026 in Munich, Germany, from 4–7 May.The compact plug-and-play BEPU is designed to replace a diesel engine within the same space, using the same mounting locations and relative machine position. It integrates the battery, motor, inverter, onboard charging, cooling and controls, enabling OEMs to electrify existing chassis platforms without extensive redesign.Caterpillar and Cat dealer Zeppelin Power Systems have be..

Next Story
Infrastructure Urban

VECV sales rise 6.9% in April 2026

VE Commercial Vehicles, a joint venture between Volvo Group and Eicher Motors, recorded sales of 7,318 units in April 2026, compared to 6,846 units in April 2025, registering 6.9 per cent growth. The total included 7,159 units under the Eicher brand and 159 units under the Volvo brand.Eicher branded trucks and buses reported sales of 7,159 units during the month, up 6.6 per cent from 6,717 units in April 2025. In the domestic commercial vehicle market, Eicher sales rose 8.6 per cent to 6,797 units from 6,257 units a year earlier.Exports declined 21.3 per cent, with VECV recording 362 units in ..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement